175 related articles for article (PubMed ID: 9927304)
1. Inhibitory and stimulatory effects of somatostatin on two human pancreatic cancer cell lines: a primary role for tyrosine phosphatase SHP-1.
Douziech N; Calvo E; Coulombe Z; Muradia G; Bastien J; Aubin RA; Lajas A; Morisset J
Endocrinology; 1999 Feb; 140(2):765-77. PubMed ID: 9927304
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin inhibits Akt phosphorylation and cell cycle entry, but not p42/p44 mitogen-activated protein (MAP) kinase activation in normal and tumoral pancreatic acinar cells.
Charland S; Boucher MJ; Houde M; Rivard N
Endocrinology; 2001 Jan; 142(1):121-8. PubMed ID: 11145574
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1).
Florio T; Yao H; Carey KD; Dillon TJ; Stork PJ
Mol Endocrinol; 1999 Jan; 13(1):24-37. PubMed ID: 9892010
[TBL] [Abstract][Full Text] [Related]
4. Direct inhibitory effects of a somatostatin analog, SMS 201-995, on AR4-2J cell proliferation via pertussis toxin-sensitive guanosine triphosphate-binding protein-independent mechanism.
Viguerie N; Tahiri-Jouti N; Ayral AM; Cambillau C; Scemama JL; Bastié MJ; Knuhtsen S; Estève JP; Pradayrol L; Susini C
Endocrinology; 1989 Feb; 124(2):1017-25. PubMed ID: 2563240
[TBL] [Abstract][Full Text] [Related]
5. Autocrine regulation of human prostate carcinoma cell proliferation by somatostatin through the modulation of the SH2 domain containing protein tyrosine phosphatase (SHP)-1.
Zapata PD; Ropero RM; Valencia AM; Buscail L; López JI; Martín-Orozco RM; Prieto JC; Angulo J; Susini C; López-Ruiz P; Colás B
J Clin Endocrinol Metab; 2002 Feb; 87(2):915-26. PubMed ID: 11836342
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2.
Buscail L; Delesque N; Estève JP; Saint-Laurent N; Prats H; Clerc P; Robberecht P; Bell GI; Liebow C; Schally AV
Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2315-9. PubMed ID: 7907795
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin receptor 1 (SSTR1)-mediated inhibition of cell proliferation correlates with the activation of the MAP kinase cascade: role of the phosphotyrosine phosphatase SHP-2.
Florio T; Thellung S; Arena S; Corsaro A; Bajetto A; Schettini G; Stork PJ
J Physiol Paris; 2000; 94(3-4):239-50. PubMed ID: 11088001
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238.
Benali N; Cordelier P; Calise D; Pages P; Rochaix P; Nagy A; Esteve JP; Pour PM; Schally AV; Vaysse N; Susini C; Buscail L
Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9180-5. PubMed ID: 10900262
[TBL] [Abstract][Full Text] [Related]
9. The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation.
Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Pattarozzi A; Bajetto A; Trapasso F; Fusco A; Schettini G
Mol Endocrinol; 2001 Oct; 15(10):1838-52. PubMed ID: 11579215
[TBL] [Abstract][Full Text] [Related]
10. sst2 Somatostatin receptor inhibits cell proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 activation.
Lahlou H; Saint-Laurent N; Estève JP; Eychène A; Pradayrol L; Pyronnet S; Susini C
J Biol Chem; 2003 Oct; 278(41):39356-71. PubMed ID: 12878607
[TBL] [Abstract][Full Text] [Related]
11. Neuronal nitric oxide synthase: a substrate for SHP-1 involved in sst2 somatostatin receptor growth inhibitory signaling.
Lopez F; Ferjoux G; Cordelier P; Saint-Laurent N; Estève JP; Vaysse N; Buscail L; Susini C
FASEB J; 2001 Oct; 15(12):2300-2. PubMed ID: 11511520
[TBL] [Abstract][Full Text] [Related]
12. Activation in vitro of somatostatin receptor subtypes 2, 3, or 4 stimulates protein tyrosine phosphatase activity in membranes from transfected Ras-transformed NIH 3T3 cells: coexpression with catalytically inactive SHP-2 blocks responsiveness.
Reardon DB; Dent P; Wood SL; Kong T; Sturgill TW
Mol Endocrinol; 1997 Jul; 11(8):1062-9. PubMed ID: 9212054
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase.
Liebow C; Reilly C; Serrano M; Schally AV
Proc Natl Acad Sci U S A; 1989 Mar; 86(6):2003-7. PubMed ID: 2564678
[TBL] [Abstract][Full Text] [Related]
14. Growth effects of regulatory peptides and intracellular signaling routes in human pancreatic cancer cell lines.
Douziech N; Lajas A; Coulombe Z; Calvo E; Lainé J; Morisset J
Endocrine; 1998 Oct; 9(2):171-83. PubMed ID: 9867251
[TBL] [Abstract][Full Text] [Related]
15. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory role of the somatostatin receptor SST2 on the intracrine-regulated cell proliferation induced by the 210-amino acid fibroblast growth factor-2 isoform: implication of JAK2.
Hortala M; Ferjoux G; Estival A; Bertrand C; Schulz S; Pradayrol L; Susini C; Clemente F
J Biol Chem; 2003 Jun; 278(23):20574-81. PubMed ID: 12665520
[TBL] [Abstract][Full Text] [Related]
17. The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling.
Lopez F; Estève JP; Buscail L; Delesque N; Saint-Laurent N; Théveniau M; Nahmias C; Vaysse N; Susini C
J Biol Chem; 1997 Sep; 272(39):24448-54. PubMed ID: 9305905
[TBL] [Abstract][Full Text] [Related]
18. Regulation of pancreatic tyrosine kinase and phosphatase activities by cholecystokinin and somatostatin.
Rivard N; Lebel D; Lainé J; Morisset J
Am J Physiol; 1994 Jun; 266(6 Pt 1):G1130-8. PubMed ID: 7912895
[TBL] [Abstract][Full Text] [Related]
19. Octapeptide somatostatin analog SMS 201-995 induces translocation of intracellular PTP1C to membranes in MCF-7 human breast adenocarcinoma cells.
Srikant CB; Shen SH
Endocrinology; 1996 Aug; 137(8):3461-8. PubMed ID: 8754775
[TBL] [Abstract][Full Text] [Related]
20. Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferation.
Ferjoux G; Lopez F; Esteve JP; Ferrand A; Vivier E; Vely F; Saint-Laurent N; Pradayrol L; Buscail L; Susini C
Mol Biol Cell; 2003 Sep; 14(9):3911-28. PubMed ID: 12972574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
